Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02358993 · ClinicalTrials.gov registry record · NA
Short-course Methenamine Hippurate for Prevention of Post-operative UTI
A NA study of Urinary Tract Infections and Catheter-Related Infections, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 201
- Enrollment target
- 4
- Study locations
NCT02358993 is a NA study of Urinary Tract Infections and Catheter-Related Infections that has completed, run by University of Pennsylvania. The registered enrollment target is 201 participants, below the 452-participant average among 34 other Urinary Tract Infections trials with a reported enrollment target (56% lower). The trial reports 4 study locations across 1 state.
The verdict
NCT02358993, a NA study of Urinary Tract Infections and Catheter-Related Infections, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 201 participants
- Enrollment target
- 4
- Study locations
Study Summary
The investigators will determine the efficacy of an innovative short regimen of methenamine hippurate on prevention of post-operative UTI in patients requiring short-term catheterization after pelvic reconstructive surgery through a single-blind, randomized controlled trial. Primary outcome will be the rate of symptomatic UTI within 3 weeks of catheter removal. The investigators will study cost-effectiveness, antibiotic resistance profiles, and adverse drug effects. Findings may reduce antibiotic use and nosocomial UTIs.
Conditions Studied
Interventions
- DRUG Ciprofloxacin
- DRUG methenamine hippurate
Study Locations (4)
Pennsylvania
- Hospital of the University of Pennsylvania - Philadelphia
- Penn Presbyterian Medical Center - Philadelphia
- Pennsylvania Hospital - Philadelphia
- Chestnut Hill Hospital - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 201 participants |
| Start Date | 2014-12 |
| Est. Completion | 2020-09-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02358993
The ClinicalTrials.gov registry entry for NCT02358993 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 201 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 452-participant average among 34 other Urinary Tract Infections trials with a reported enrollment target (56% lower). The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Urinary Tract Infections appearing as the primary indexed condition, and to 2 interventions - of which Ciprofloxacin is the first listed.
NCT02358993 reports 4 study locations spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT02358993 about?
NCT02358993 is a clinical study titled "Short-course Methenamine Hippurate for Prevention of Post-operative UTI". The investigators will determine the efficacy of an innovative short regimen of methenamine hippurate on prevention of post-operative UTI in patients requiring short-term catheterization after pelvic reconstructive surgery through a single-blind, randomized controlled trial. Primary outcome will be ...
What is the current status of trial NCT02358993?
This trial is currently completed. It is a NA study. The enrollment target is 201 participants. The study started on 2014-12. Estimated completion is 2020-09-30.
What conditions does trial NCT02358993 study?
This clinical trial studies the following conditions: Urinary Tract Infections, Catheter-Related Infections.
What interventions are being tested in trial NCT02358993?
The interventions under investigation include: Ciprofloxacin (DRUG), methenamine hippurate (DRUG).
Who is sponsoring clinical trial NCT02358993?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02358993 being conducted?
This trial has 4 study locations across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Urinary Tract Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Application of a Prediction Model for Directing Antibiotic Use in the Treatment of Urinary Tract Infection in an Ambulatory Setting
RECRUITING · NA
-
Follow-up Automatically vs. As-Needed Comparison (FAAN-C) Trial
RECRUITING · NA
-
Double Voiding and Post-transplant UTI
RECRUITING · NA
-
Diagnosis and Treatment of Urinary Tract Infection Using DNA Polymerase Chain Reaction Versus Urine Culture
RECRUITING · NA
-
Effect of Standardization of Urine Collection Using PEEZY Device as Compared to Clean Peezy for DAB
ACTIVE NOT RECRUITING · NA
-
Cranberry Tablets Versus Nitrofurantoin Prophylaxis for Urinary Tract Infection Prevention After Urogynecologic Surgery
ACTIVE NOT RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.